Johnson & Johnson Settles Opioid Case with New Mexico
18 Janeiro 2022 - 02:26AM
TipRanks
Johnson & Johnson (JNJ) announced on Friday that it has agreed
to settle the opioid epidemic case with New Mexico by paying $44
million. Shares of the global drug maker closed at $167.84 on
January 14. New Mexico had originally ruled out of participating in
a nationwide settlement resolving several similar cases. JNJ said
the $44 million was consistent with the terms of a proposal for
J&J as well as other drug makers McKesson Corp. (MCK),
AmerisourceBergen Corp. (ABC), and Cardinal Health Inc. (CAH).
These drug manufacturers have collectively decided to pay up to $26
billion to resolve the cases across the U.S.
https://www.tipranks.com/news/jnj-settles-opioid-case-with-new-mexico?utm_source=advfn.com&utm_medium=referral
Johnson and Johnson (NYSE:JNJ)
Gráfico Histórico do Ativo
De Abr 2022 até Mai 2022
Johnson and Johnson (NYSE:JNJ)
Gráfico Histórico do Ativo
De Mai 2021 até Mai 2022